Detalles de la búsqueda
1.
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
J Clin Oncol
; 18(10): 2095-103, 2000 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-10811675
Mostrar más
2.
Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.
Semin Oncol
; 22(2 Suppl 4): 22-9, 1995 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-7740327
3.
A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).
Lung Cancer
; 27(3): 145-57, 2000 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-10699688
4.
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice.
Lung Cancer
; 29(3): 205-16, 2000 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-10996423
5.
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer.
Anticancer Drugs
; 11(1): 7-13, 2000 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-10757557
6.
Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experience.
Invest New Drugs
; 16(3): 265-70, 1998.
Artículo
en Inglés
| MEDLINE | ID: mdl-10360607
Resultados
1 -
6
de 6
1
Próxima >
>>